Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Senate committee approves bill to set Medicaid reimbursement for vagus nerve stimulators amid DHS caution
Summary
HB 1810, presented by Sen. Brianne Davis, would establish device reimbursement rates for vagus nerve stimulation therapy under Arkansas Medicaid; industry witnesses cited large reductions in ER visits and hospitalizations, while DHS warned the change likely requires a CMS state plan amendment with potential federal review of hospital supplemental payment systems.
The Public Health, Welfare and Labor Committee approved HB 1810 after testimony from the sponsor, industry representatives and Department of Human Services officials.
Sen. Brianne Davis described the bill as establishing device reimbursement rates for vagus nerve stimulation therapy devices by setting reimbursement equal to a percentage of device cost or aligning with Medicare reimbursement under an amendment. An industry representative representing the device manufacturer said the lack of separate device…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
